Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Earnings Rebound ⢠Negative Cash Flow ⢠High Leverage AGL's reported earnings have rebounded, but persistent negative cash flow, tight liquidity, and high liability leverage make the recovery high-risk.
Price Behavior
Key Price Behavior Insights: ⢠Range-bound trading ⢠Support rebound ⢠Resistance rejection Support Level: $86.30â$87.50 Resistance Level: $93.60â$97.00 AGL was range-bound last month with weak momentum; hold above $86.30â$87.50 and reclaim $92.30/$93.60 for recovery, while a break below support signals downside risk.
Sentiment & News
Key News Insights: ⢠Investor conferences ⢠Pennsylvania expansion ⢠ACO partnership agilon Health is boosting investor engagement while expanding its physician network through a major Pennsylvania ACO partnership, supporting growth visibility.
AI Summary
agilon health is a turnaroundânot yet a proven cash-generative growth storyâso investors should wait for sustained positive operating cash flow and stable medical margins before underwriting its raised guidance, despite credible upside from expanding physician/ACO partnerships.
Description
agilon health, inc. provides healthcare services for senior patients through primary care physicians in communities across the United States. As of December 31, 2021, the company served about 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. Founded in 2016 and based in Austin, Texas, the company adopted its current name in March 2021.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 10 | Jun 17 | AGL | Agilon Health, Inc. | Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range. | Closed | +2.9% |
| May 21 | May 28 | AGL | Agilon Health, Inc. | High-risk but clear short-term momentum catalyst: 2026-05-06 Q1 update beat estimates and raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA. Stock surged sharply after earnings and is up about 206% over 21 trading days. | Closed | +12.2% |